FDA's GenAI Guidance Gap Puts Lifecycle Design on the Critical Path
FDA is still soliciting input on generative AI device oversight while conventional AI/ML tools keep clearing through 510(k), forcing sponsors to design lifecycle monitoring ahead of guidance.